“…Many studies have highlighted the strong potential of commercial anion exchange resins (AERs) to remove pharmaceuticals from various water matrices (Michael-Kordatou et al, 2015) (e.g., MIEX ® resins for seven sulfonamide antibiotics, seven tetracyclic antibiotics (Choi et al, 2007), estrone (Neale et al, 2010), triclosan, and sulfamethoxazole (SMX) (Huang et al, 2011); Lewatit MP500 resins for SMX and sulfamethazine (Fern andez et al, 2014); Purolite A520E resins for diclofenac (DCF) (Landry and Boyer, 2013); Dowex 22 resins for DCF, ketoprofen, and naproxen (NPX), ibuprofen, paracetamol (Landry et al, 2015); IRA938, IRA958, IRA458, and IRA402 resins for nalidixic acid (Robberson et al, 2006); and Oasis MAX resin for caffeine and metformin (B€ auerlein et al, 2012)). Due to the presence of various functional groups (e.g., eOH, eCOONa, eSO 3 Na, eN]Ne, and phenolic hydroxyl groups), many pharmaceutical molecules can simultaneously participate in both electrostatic interactions (i.e., Coulombic forces between the positively charged quaternary ammonium functional groups of AERs and the anionic moieties of pharmaceuticals) and various non-electrostatic interactions (B€ auerlein et al, 2012).…”